Generic Drug Patents: How Exclusivity Periods Vary Across Countries
- by Lysander Beaumont
- Jan, 9 2026
Generic drug exclusivity periods vary widely across countries, affecting how quickly affordable versions reach patients. The U.S. uses complex patent stacking and 180-day incentives, while the EU follows a clearer 8+2+1 model. These rules shape drug prices, innovation, and global access.
Read More
